2,710
Views
0
CrossRef citations to date
0
Altmetric
Cardiovascular

Comparative evaluation of costs and healthcare resource utilization of oral selexipag versus inhaled treprostinil or oral treprostinil in patients with pulmonary arterial hypertension

ORCID Icon, , , , &
Pages 644-655 | Received 02 Mar 2023, Accepted 17 Apr 2023, Published online: 07 May 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.